MedPath

Breast Cancer Rates Rise Disproportionately Among Minority Women, SEER Data Shows

  • New analysis of SEER data reveals breast cancer incidence rates increased by 0.5% annually from 2010-2019, with highest rises among Asian/Pacific Islander (2.1%), American Indian/Alaska Native (1.9%), and Hispanic women (1.4%).

  • Triple-negative breast cancer shows alarming growth among older minority women, with annual increases of 5.5% in Asian/Pacific Islanders, 4.3% in Black women, and 2.3% in Hispanic women aged 65 and older.

  • Study analyzing 1.12 million breast cancer cases highlights significant racial disparities, with Black women facing 40% higher mortality rates despite similar diagnosis rates compared to White women.

A comprehensive analysis of U.S. cancer registry data has revealed concerning disparities in breast cancer incidence rates across racial and ethnic groups, with minority women experiencing disproportionately higher increases in recent years.
The study, published in JAMA Network Open, examined data from 1,123,658 women diagnosed with invasive breast cancer across 22 U.S. cancer registries between 2010 and 2019. While overall breast cancer rates increased by 0.5% annually, the impact varied significantly among different demographic groups.

Striking Disparities in Incidence Rates

Non-Hispanic Asian or Pacific Islander women experienced the highest annual increase at 2.1%, followed by non-Hispanic American Indian or Alaska Native women at 1.9%, and Hispanic women at 1.4%. In comparison, non-Hispanic Black and White women showed more modest increases of 0.8% and 0.5%, respectively.
The findings are particularly alarming given existing mortality disparities. Between 2015 and 2019, non-Hispanic Black women faced a 40% higher mortality rate compared to non-Hispanic White women, despite similar diagnosis rates.

Triple-Negative Breast Cancer Trends

Perhaps most concerning is the sharp rise in triple-negative breast cancer (TNBC) among older minority women. Women aged 65 and older showed dramatic increases in TNBC incidence:
  • 5.5% annual increase among non-Hispanic Asian or Pacific Islander women
  • 4.3% annual increase among non-Hispanic Black women
  • 2.3% annual increase among Hispanic women
  • No significant change among non-Hispanic White women
These trends are particularly worrisome as TNBC is known for its aggressive nature and limited treatment options.

Research Implications and Limitations

The study's lead researchers note that understanding these disparities is crucial for developing targeted interventions. "A current gap in knowledge is how breast cancer subtype–specific incidence rates vary by race and ethnicity and age over the past decade," they wrote, emphasizing the importance of tracking these changes.
However, the study faced several limitations. The analysis couldn't account for key breast cancer risk factors such as reproductive history, body mass index, and lifestyle factors. Additionally, the potential for misclassification in race and ethnicity data, which was extracted from medical records, could affect the findings' accuracy.

Future Directions

The researchers emphasize the urgent need for further investigation into the factors driving these disparities, particularly in aggressive subtypes like TNBC. Understanding these trends will be crucial for developing targeted public health strategies and improving outcomes across all demographic groups.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

© Copyright 2025. All Rights Reserved by MedPath